Bard Associates Inc Vivos Therapeutics, Inc. Transaction History

Bard Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.35 - $20.75 $5,250 - $311,250	-15,000 Reduced 6.92%	201,704 $80,000
Q2 2022 Aug 11, 2022	BUY	$1.12 - $2.18 $4,480 - $8,720	4,000 Added 1.88%	216,704 $280,000
Q1 2022 May 11, 2022	SELL	$1.63 - $3.63 $1,300 - $2,896	-798 Reduced 0.37%	212,704 $570,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $4,495 - $8,211	-1,998 Reduced 0.93%	213,502 $480,000
Q2 2021 Aug 12, 2021	BUY	$4.83 - $9.67 $1.04 Million - $2.08 Million	215,500 New	215,500 $1.07 Million

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.